Lorcaserin

CAS No. 616202-92-7

Lorcaserin( Lorcaserin | Belviq | Belvig | HSDB 8128 )

Catalog No. M15327 CAS No. 616202-92-7

Lorcaserin(APD356) is a selective full agonist of human 5-HT2C receptor with Ki of 15 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Lorcaserin
  • Note
    Research use only, not for human use.
  • Brief Description
    Lorcaserin(APD356) is a selective full agonist of human 5-HT2C receptor with Ki of 15 nM.
  • Description
    Lorcaserin(APD356) is a selective full agonist of human 5-HT2C receptor with Ki of 15 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Lorcaserin | Belviq | Belvig | HSDB 8128
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT2C
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    616202-92-7
  • Formula Weight
    195.69
  • Molecular Formula
    C11H14ClN
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    C[C@H]1CNCCC2=CC=C(Cl)C=C12
  • Chemical Name
    (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chan EW, et al. Obes Rev. 2013 Jan 2
molnova catalog
related products
  • Promethazine

    Tafluprost(AFP-168) is an anti-glaucoma prostaglandin (PG) analog.

  • RS 102221

    A highly potent, selective 5-HT2C receptor antagonist with pKi of 8.4 and 8.5 for human and rat 5-HT2C, respectively.

  • SEP-363856 hydrochlo...

    SEP-363856 hydrochloride is an agent of orally active and CNS active psychotropic with a unique, non-D2/5-HT2A mechanism of action, exerts its antipsychotic-like effects, has the potential to treatment of schizophrenia. SEP-856 (10μM) specifically inhibits α2A, α2B, D2, 5-HT1A, 5-HT1B, 5-HT1D, 5-HT2A, 5-HT2B, 5-HT2C and 5-HT7> 50% receptor.